Get the Stockscreener App
68.34
0.14%
0.010
Hinge Health Inc stock is traded at $68.34, with a volume of 562.25K.
It is up +0.14% in the last 24 hours and up +25.59% over the past month.
Hinge Health Inc is a technology platform for individuals seeking to treat and prevent joint and muscle pain. Through a combination of AI-powered motion tracking technology, the Company's platform helps members address chronic musculoskeletal (MSK) conditions, enables improved member outcomes and supports cost reductions for its clients.
See More
Previous Close:
$68.35
Open:
$69.03
24h Volume:
562.25K
Relative Volume:
0.43
Market Cap:
$5.29B
Revenue:
$646.34M
Net Income/Loss:
$-512.40M
P/E Ratio:
-10.22
EPS:
-6.6871
Net Cash Flow:
$202.76M
1W Performance:
+9.02%
1M Performance:
+25.59%
6M Performance:
+41.39%
1Y Performance:
+89.02%
1-Day Range:
$67.59
$70.72
1-Week Range:
$61.50
$70.72
52-Week Range:
$30.08
$70.72
Hinge Health Inc Stock (HNGE) Company Profile
Name
Hinge Health Inc
Sector
Industry
Phone
415-689-8429
Address
455 MARKET STREET, SAN FRANCISCO
Compare HNGE vs VEEV, BTSG, TEM, HQY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HNGE
Hinge Health Inc
|
68.38 | 5.29B | 646.34M | -512.40M | 202.76M | -6.6871 |
VEEV
Veeva Systems Inc
|
160.66 | 26.34B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
64.60 | 12.58B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
52.70 | 9.39B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
85.91 | 7.27B | 1.34B | 230.70M | 440.96M | 2.6695 |
Hinge Health Inc Stock (HNGE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-09-26 | Initiated | Wells Fargo | Overweight |
| Sep-05-25 | Initiated | Robert W. Baird | Neutral |
| Jul-14-25 | Initiated | Citizens JMP | Mkt Outperform |
| Jun-16-25 | Initiated | Barclays | Overweight |
| Jun-16-25 | Initiated | BofA Securities | Buy |
| Jun-16-25 | Initiated | Canaccord Genuity | Buy |
| Jun-16-25 | Initiated | Evercore ISI | Outperform |
| Jun-16-25 | Initiated | KeyBanc Capital Markets | Overweight |
| Jun-16-25 | Initiated | Morgan Stanley | Overweight |
| Jun-16-25 | Initiated | Needham | Buy |
| Jun-16-25 | Initiated | Piper Sandler | Overweight |
| Jun-16-25 | Initiated | RBC Capital Mkts | Outperform |
| Jun-16-25 | Initiated | Raymond James | Outperform |
| Jun-16-25 | Initiated | Stifel | Buy |
| Jun-16-25 | Initiated | Truist | Buy |
| Jun-16-25 | Initiated | William Blair | Outperform |
View All
Hinge Health Inc Stock (HNGE) Latest News
Alkeon Capital Management LLC Purchases 415,093 Shares of Hinge Health Inc. $HNGE - MarketBeat
HNGE Maintains by Raymond James -- Price Target Raised to $80 - GuruFocus
Hinge Health expands HingeSelect to offer end-to-end MSK surgical care - MSN
Canaccord raises Hinge Health stock price target on growth outlook By Investing.com - Investing.com Canada
Canaccord raises Hinge Health stock price target on growth outlook - Investing.com
Hinge Health (HNGE) Stock Valuation Split Between Bearish Narrative And Optimistic Cash Flow Outlook - Yahoo Finance
Bullseye Asset Management LLC Acquires Shares of 41,763 Hinge Health Inc. $HNGE - MarketBeat
Hinge Health, Inc. (HNGE) Analyst/Investor DaySlideshow (NYSE:HNGE) 2026-06-13 - Seeking Alpha
Needham raises Hinge Health stock price target on guidance boost By Investing.com - Investing.com Nigeria
HNGE Maintained by Keybanc -- Price Target Raised to $90.00 - GuruFocus
Is Hinge Health a Stock to Sell After an Insider Sold 50,000 Shares? - Yahoo Finance
Bessemer funds tied to Hinge Health (NASDAQ: HNGE) report June share sales - Stock Titan
Is Hinge Health a Stock to Sell After an Insider Sold 50,000 Shares? - The Motley Fool
KeyBanc raises Hinge Health stock price target on surgery expansion By Investing.com - Investing.com Australia
KeyBanc raises Hinge Health stock price target on surgery expansion - Investing.com
Citizens maintains Hinge Health stock rating on customer conference By Investing.com - Investing.com Australia
Citizens maintains Hinge Health stock rating on customer conference - Investing.com UK
Hinge Health stock hits all-time high at 66.6 USD By Investing.com - Investing.com Nigeria
RBC Capital Maintains Hinge Health(HNGE.US) With Buy Rating, Raises Target Price to $75 - Moomoo
HNGE Maintained by RBC Capital -- Price Target Raised to $75.00 - GuruFocus
Hinge Health stock hits all-time high at 66.6 USD - Investing.com
HNGE Maintained by Truist Securities -- Price Target Raised to $85 - GuruFocus
Hinge Health's New Products, Margin Gains Support Growth Outlook, RBC Says - Moomoo
Truist raises Hinge Health stock price target on growth outlook By Investing.com - Investing.com Australia
HNGE Maintained by Barclays -- Price Target Raised to $70 - GuruFocus
Hinge Health (NYSE:HNGE) Price Target Raised to $85.00 at Truist Financial - MarketBeat
Hinge Health Is Maintained at Outperform by RBC Capital - Moomoo
Truist raises Hinge Health stock price target on growth outlook - Investing.com
Hinge Health Expands HingeSelect to Offer End-to-End MSK Surgical Care - Zacks Investment Research
Truist Raises Price Target on Hinge Health to $85 From $79, Keeps Buy Rating - Moomoo
A Quick Look at Today's Ratings for Hinge Health(HNGE.US), With a Forecast Between $65 to $85 - Moomoo
HNGE Maintains Buy Rating -- Price Target Raised to $76.00 by Ne - GuruFocus
Hinge Health raises Q2 and FY 2026 guidance; projects above estimate - MSN
Stifel reiterates Hinge Health stock rating on surgical expansion - Investing.com UK
Needham & Company LLC Increases Hinge Health (NYSE:HNGE) Price Target to $76.00 - MarketBeat
Stifel reiterates Hinge Health stock rating on surgical expansion By Investing.com - Investing.com Australia
Needham raises Hinge Health stock price target on guidance boost - Investing.com
RBC Raises Price Target on Hinge Health to $75 From $65, Keeps Outperform Rating - marketscreener.com
RBC Capital raises Hinge Health stock price target on guidance boost By Investing.com - Investing.com South Africa
RBC Capital raises Hinge Health stock price target on guidance boost - Investing.com
Hinge Health Inc (HNGE) PT Raised to $76 at Needham - StreetInsider
Hinge Health Inc (HNGE) PT Raised to $75 at RBC Capital - StreetInsider
HNGE: Unified care platform, AI-driven growth, and new products fuel strong financial outperformance - TradingView
Hinge Health adds surgery to HingeSelect, delivering a fully integrated musculoskeletal care platform - 01net
Piper Sandler reiterates Hinge Health stock rating at Overweight By Investing.com - Investing.com Nigeria
Piper Sandler reiterates Hinge Health stock rating at Overweight - Investing.com
Hinge Health Inc Stock (HNGE) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.01%
0.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):